Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02434523 · ClinicalTrials.gov registry record · Phase 2
Trial of the Treatment of Chronic Laryngitis With Amitryptiline
A Phase 2 study, sponsored by Boston Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT02434523: Clinical Trial Phase 2 study, sponsored by Boston Medical Center.
NCT02434523 is a Phase 2 study that was terminated before completion, run by Boston Medical Center. The registered enrollment target is 30 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02434523, a Phase 2 study, was terminated before completion, sponsored by Boston Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The study will compare the effectiveness of amitriptyline versus placebo (inactive medication) in treating chronic laryngitis.
Primary Outcome
Reflux symptom index change in score after treatment Range possible: 0 to 45 Higher values indicate worse symptoms / outcomes
Interventions
- OTHER Placebo
- DRUG Amitriptyline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-01 |
| Phase | Phase 2 |
Why NCT02434523 stopped before completion
NCT02434523 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02434523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02434523 about?
NCT02434523 is a clinical study titled "Trial of the Treatment of Chronic Laryngitis With Amitryptiline". The study will compare the effectiveness of amitriptyline versus placebo (inactive medication) in treating chronic laryngitis.
What is the current status of trial NCT02434523?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2013-09. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02434523?
The interventions under investigation include: Placebo (OTHER), Amitriptyline (DRUG).
Who is sponsoring clinical trial NCT02434523?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02434523's enrollment target sits among peer trials
30 1582nd of 2000 higher than 332 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia